Abducens palsy............................................................................... 179 Age-related macular degeneration............................................... 235 Alkali burn...................................................................................... 182 Angioid streaks............................................................................... 268 Anterior segment optical coherence tomography...................... 132 Behçet’s............................................................................................. 146 Biomicroscopy................................................................................ 132 Bleb................................................................................................... 132 Blue-light ........................................................................................ 235 Break-up time................................................................................. 142 Cerebral venous sinus thrombosis............................................... 179 Chemoreduction............................................................................. 259 Choroidal thickness....................................................................... 239 Clinical activity score..................................................................... 156 Comet lesions.................................................................................. 268 Confocal microscopy..................................................................... 188 Conjunctival autograft................................................................... 249 Conjunctival flora........................................................................... 193 Cornea............................................................................................. 226 Cornea endothelial cell density.................................................... 188 Corneal perforation....................................................................... 239 Cyclopentolate................................................................................ 220 Dengue fever .................................................................................. 223 Diabetes mellitus............................................................................ 193 Diplopia........................................................................................... 175 Dose.................................................................................................. 197 Double-headed pterygium............................................................ 249 Downshoot...................................................................................... 152 Dry eye............................................................................................. 138 Duane retraction syndrome.......................................................... 152 Endoscopic sinus surgery.............................................................. 175 Entropion......................................................................................... 203 Exenteration.................................................................................... 169 External dacryocystorhinostomy................................................. 208 Extraocular muscle injury............................................................. 175 Eye.................................................................................................... 213 Eyelid surgery.................................................................................. 203 Familial exudative vitreoretinopathy........................................... 164 Flavivirus......................................................................................... 223 Functional nasolacrimal drainage obstruction.......................... 208 Fundus autofluorescence............................................................... 235 FZD4................................................................................................ 164 Galilei............................................................................................... 243 Ganglion cell complex................................................................... 229 Globe retraction.............................................................................. 152 Gram-negative bacteria................................................................. 193 Heart failure.................................................................................... 179 HELLP syndrome........................................................................... 271 Homocysteine................................................................................. 146 In vivo confocal microscopy......................................................... 132 Infantile esotropia.......................................................................... 197 Infliximab........................................................................................ 138 Interobserver repeatability............................................................ 243 Intra-arterial chemotherapy.......................................................... 259 Intraobserver................................................................................... 243 Intravitreal chemotherapy............................................................. 259 Keratitis............................................................................................ 220 Lacrimal scintigraphy.................................................................... 208 Leptin............................................................................................... 146 LRP5................................................................................................. 164 Macular hemorrhage...................................................................... 271 Macular hole................................................................................... 274 Macular thickness........................................................................... 239 Medical treatment.......................................................................... 182 Meibomianitis................................................................................. 203 Mucormycosis................................................................................. 169 NDP.................................................................................................. 164 Near-infrared autofluorescence.................................................... 235 Ocular diseases in pregnancy....................................................... 213 Ocular hypertension...................................................................... 229 Ocular surface................................................................................. 182 Ophthalmomyiasis externa........................................................... 220 Optical coherence tomography.................................................... 274 Optical low-coherence reflectometry.......................................... 188 Orbital decompression.................................................................. 156 Orbital involvement....................................................................... 169 Orbital radiotherapy...................................................................... 156 Osmolarity....................................................................................... 142 Parkinson’s....................................................................................... 142 Pattern electroretinogram............................................................. 229 Peripapillary retinal nerve fiber layer thickness......................... 239 Photokeratitis.................................................................................. 226 Preeclampsia................................................................................... 271 Pregnancy........................................................................................ 213 Primary open-angle glaucoma..................................................... 229 Pseudoexfoliation glaucoma......................................................... 188 Pseudoxanthoma elasticum.......................................................... 268 Pterygium........................................................................................ 249 Recession......................................................................................... 197 Resection......................................................................................... 197 Response.......................................................................................... 197 Retina............................................................................................... 223 Retinal nerve fiber layer................................................................. 229 Retinal vascularcaliber................................................................... 239 Retinoblastoma............................................................................... 259 Schirmer’s........................................................................................ 142 Secondary........................................................................................ 254 Senile cataract................................................................................. 188 Sensory............................................................................................. 254 Serous retinal detachment............................................................. 271 Sjögren’s syndrome......................................................................... 138 Smoking........................................................................................... 156 Strabismus................................................................................175,254 Subconjunctival chemotherapy.................................................... 259 Surgery............................................................................................. 197 Surgical treatment.......................................................................... 182 Tear................................................................................................... 142 Thyroid-associated ophthalmopathy........................................... 156 Treatment of the eye during pregnancy...................................... 213 Trichiasis.......................................................................................... 203 TSPAN12......................................................................................... 164 Tumor necrosis factor.................................................................... 138 Ultraviolet........................................................................................ 226 Upshoot........................................................................................... 152 Uveitis.............................................................................................. 146 Visual acuity.................................................................................... 254 Vitrectomy....................................................................................... 274 Wavefront aberrations................................................................... 243
2015 Subject Index
Other
2015 Subject Index
Turk J Ophthalmol 2015;45(6):0-0
Licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND) International License.
CC BY-NC-ND — Attribution-NonCommercial-NoDerivatives 4.0 InternationalThe statements, opinions, and data contained in articles published in this journal are solely those of the individual author(s) and contributor(s) and do not necessarily reflect the views of the journal, its editors, editorial board, owner, or Galenos Publishing House.
Neither the journal nor Galenos Publishing House endorses or recommends any commercial product, process, service, institution, or organization that may be mentioned or advertised in the journal. The publication of advertisements, product information, or links to external websites does not constitute endorsement or approval by the journal or the publisher.
The journal, its editors, editorial board, owner, and Galenos Publishing House make reasonable efforts to ensure the accuracy and integrity of published content; however, they cannot be held responsible for errors, omissions, or any consequences arising from the use of information contained in the journal, to the extent permitted by applicable law.
Information published in the journal is intended for scientific and educational purposes and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Readers should consult appropriately qualified healthcare professionals regarding individual medical conditions or treatment decisions.
External links are provided for informational convenience only. The journal and Galenos Publishing House are not responsible for the availability, accuracy, content, privacy practices, or policies of external websites.


